A comparative clinical study of the effects of the traditional Chinese medicine Jinniu capsules and lofexidine on acute heroin withdrawal symptoms.

National Institute on Drug Dependence, Peking University, Beijing, China.
The American Journal of Drug and Alcohol Abuse (Impact Factor: 1.47). 02/2008; 34(6):792-800. DOI: 10.1080/00952990802491563
Source: PubMed

ABSTRACT Jinniu capsules, comprised of herbs and marine product extracts, are traditionally used in Chinese medicine. In this randomized multicenter clinical trial we evaluated the efficacy and safety of Jinniu capsules used to treat the symptoms of heroin withdrawal, as compared with lofexidine.
Two hundred and twelve patients with heroin dependence were randomly assigned to the Jinniu capsule or lofexidine treatment groups during a 10-day double-blind clinical trial. The severity of their opiate withdrawal symptoms was measured daily for 10 days. Anxiety was measured on days 0, 5, and 10. Safety assessment of the drugs included measurement of vital signs and side effects, as well as laboratory tests.
Withdrawal symptom and anxiety scores decreased gradually over the treatment period, and no significant differences were found between two groups. No severe adverse events occurred during the treatment.
Jinniu capsules may be an effective and safe agent in the management of opiate withdrawal.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Objective: In this study, the current literatures on the use of herbs and herbal preparations of Traditional Chinese and Indian Medicine for the treatment of opioid addiction were reviewed. Matherials and Methods: Search was done in databases such as Pub Med, Science Direct, Scopus, Springer Link, and Google Scholar. Results: Among 18 retrieved studies, 3 studies were about asafetida extract, an approved preparation for ameliorating drug abstinence in China. Chinese preparations including Composite Dong Yuan Gao, Qingjunyin and TJ-97 (a water extract of dai-bofu-to) as well as Indian ones, Mentate and Shilajit, were reported to have positive effects against opioid withdrawal, dependence, and tolerance. Moreover, Levo-tetrahydropalmatine and L-Stepholidine, in addition to extracts of Caulis Sinomenii and Sinomenium acutum showed similar effects. Banxia Houpu Decoction, Fu-Yuan pellet, Jinniu capsules, Qingjunyin, Tai-Kang-Ning capsule, and Xuan Xia Qudu Jiaonang (WeiniCom) from Chinese preparations, showed anti-addiction effects in randomized, double-blind and, in some studies, multicenter clinical trials. Conclusion : Traditional herbal preparations of China and India have anti-addiction effects with less adverse effects than alpha2-adrenergic or opioid agonists.
    Avicenna Journal of Phytomedicine 03/2013; 3(3-3):205-215.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Medication assisted treatment (MAT) is a key component in overdose prevention, reducing illicit opiate use and risk of blood borne virus infection. By retaining participants in MAT programs for longer periods of time, more noticeable and permanent changes in drug use, risk behavior, and quality of life can be achieved. Many studies have documented retention in MAT programs in high-income countries, using a 50% average 12-month follow-up retention rate as a marker for a successful MAT program. This study contributes to a systematic understanding of how successful programs have been in retaining participants in low and middle-income countries (LMIC) over time. Using Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines we conducted a systematic literature search to identify MAT program studies that documented changes in retention over time for participants in buprenorphine and methadone programs in LMIC. Retention was measured for participants by length of follow-up, type of MAT, and treatment dosage. There were 58 MAT program studies with 27,047 participants eligible for inclusion in the review. Overall average retention after 12 months was 54.3% (95% CI: 46.2%, 63.7%). Overall average retention was moderately good for both buprenorphine (48.3%, 95% CI: 22.1%, 74.6%) and methadone (56.6%, 95% CI: 45.9%, 67.3%), after 12 months of treatment. Among programs using methadone there was no statistically significant difference in average retention by dosage level, and the 10 highest and lowest dosage programs obtained similar average retention levels after 12 months. Medication Assisted Treatment programs in Low and Middle Income Countries achieve an average 50% retention rate after 12 months with wide variation across programmes but little difference between those using buprenorphine versus methadone.
    Addiction 07/2013; 109(1). DOI:10.1111/add.12303 · 4.60 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Amphetamine-type stimulants (ATS) have quickly spread and been widely abused in many parts of the world, particularly in China. This review focuses on and describes the epidemiological trends and the advances of treatments of ATS in China. A descriptive study based on literature identified from searches of the China National Knowledge Infrastructure (1979-2013), PubMed databases, hand-picked references, and online references with emphasis on epidemiology, treatment and traditional Chinese medicine. This review covers some traditional Chinese treatments and their complementary Western approaches. The epidemiological trends of ATS in China have led to its being 2.2 times the rate of morphine abuse and second only to marijuana abuse. The treatment programs in China have used traditional herbal approaches as well as acupuncture, often in combination with Western medications such as fluoxetine for depression associated with ATS abuse. Other herbal treatments have reversed the cardiac arrhythmias associated with ATS intoxication, and acupuncture has been used successfully for the protracted depressive and somatic symptoms of ATS withdrawal over a period of 3 months. These traditional Chinese treatments may be increasingly available to the world, but will remain a consistent complementary therapy for ATS in China and the Far East, where ATS has become such a prevalent problem. (Am J Addict 2013;XX:000-000).
    American Journal on Addictions 09/2013; DOI:10.1111/j.1521-0391.2013.12116.x · 1.74 Impact Factor